The plasma membrane as a combat zone in the HIV battlefield

Genes and Development

Volumn 14, Issue 21, 2000, Pages 2677-2688

  Doms, Robert W ^a   Trono, Didier ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ENVELOPE PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

CELL MEMBRANE; CELL SURFACE; CONFORMATIONAL TRANSITION; HUMAN IMMUNODEFICIENCY VIRUS; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; RECEPTOR BINDING; REVIEW; VIRUS INFECTIVITY;

ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL MEMBRANE; DENDRITIC CELLS; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, ENV; GENE PRODUCTS, NEF; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HUMANS; LECTINS; LECTINS, C-TYPE; MEMBRANE FUSION; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PROTEIN CONFORMATION; RECEPTORS, CCR5; RECEPTORS, CELL SURFACE; RECEPTORS, CXCR4; RECEPTORS, HIV; VIRUS ASSEMBLY; VIRUS REPLICATION; VIRUS SHEDDING;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0034312298     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.833300     Document Type: Review

References (133)

1. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain
2. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cell
3. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
4. HIV and SIV gp120 binding does not predict coreceptor function
5. Solution structure of a polypeptide from the N terminus of the HIV protein Nef
6. Physical interaction of the HIV-1 Nef protein with β-COP, a component of non-clathrin-coated vesicles essential for membrane traffic
7. A new classification for HIV-1
8. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
9. Chemokine receptors and human immunodeficiency virus infection
10. Putting together an MHC class I molecule
11. The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: Implications for the mechanism of degradation
12. A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor
13. Human pathogen subversion of antigen presentation
14. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical surface
15. Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells
16. N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates
17. Core structure of gp41 from the HIV envelope glycoprotein
18. HIV entry and its inhibition
19. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef
20. Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells
21. Identification of determinants on a dual-tropic human immunodeficiency virus type-1 envelope glycoprotein that confer usage of CXCR4
22. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
23. Specific cell surface requirements for infection of CD4-positive cells by human immunodeficiency virus type 1, type 2 and by simian immunodeficiency virus
24. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells
25. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
26. Direct interaction between the envelope and matrix proteins of HIV-1
27. Interaction of HIV-1 nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity
28. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCRS
29. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients
30. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
31. Polarized human immunodeficiency virus budding in lymphocytes involves a tyrosine-based signal and favors cell-to-cell transmission
32. HIV coreceptor use: A molecular window into viral tropism
33. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events
34. Identification of CXCR4 domains that support coreceptor and chemokine receptor functions
35. A binding pocket for a small molecule inhibitor of HIV entry within the transmembrane helices of CCR5
36. Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket
37. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency viruses
38. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by neurovirulent SIV
39. Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains
40. Chemokine and orphan receptors in HIV-2 and SIV tropism and pathogenesis
41. Tyrosine sulfonation of the amino terminus of CCR5 facilitates HIV-1 entry
42. Role of β-arrestin in mediating agonist-promoted G protein-coupled receptor internalization
43. Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements
44. Nef-mediated clathrin coated pit formation
45. Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors
46. Capture of an early fusion-active conformation of gp41
47. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
48. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses
49. 1 receptor for substance P and a non-peptide antagonist
50. The immunological synapse: A molecular machine controlling T cell activation
51. A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4
52. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes
53. The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase
54. The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR
55. Refined solution structure and backbone dynamics of HIV-1 Nef
56. Virus-cell and cell-cell fusion
57. Chemokines and coreceptors in HIV/SIV-host interactions
58. Human immunodeficiency virus type 1 envelope determinants of the CCR2b, CCR3, STRL33, and APJ coreceptors
59. Stable exposure of the coreceptor binding site in a CD4-independent HIV-1 envelope protein
60. The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques
61. Downregulation of HLA class I antigens in HIV-1 infected cells
62. Importance of the nef gene for maintenance of high viral loads and for development of AIDS
63. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
64. CD4, CXCR-4, and CCR5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1
65. Cooperation of multiple coreceptors for infections by human immunodeficiency virus type I
66. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
67. Fusion-competent vaccines: Broad neutralization of primary isolates of HIV
68. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner
69. Evidence for cell-surface association between Fusin and the CD4-gp120 complex in human cell lines
70. HIV requires multiple gp120 molecules for CD4-mediated infection
71. Chemokine immunobiology in HIV-1 pathogenesis
72. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function
73. Quantification of CD4, CCRS, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
74. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain
75. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophage-tropic isolates of human immunodeficiency virus type 1
76. Nef interacts with the μ subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC-I molecules
77. Distinct pathways mediate Nef-induced and clathrin-dependent MHC-I downregulation
78. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
79. Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions
80. Two elements target SIV nef to the AP-2 clathrin adaptor complex, but only one is required for the induction of CD4 endocytosis
81. The membrane-proximal intracytoplasmic residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells
82. Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4
83. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
84. The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane
85. Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal α-helix and proline repeat of Nef selectively regulate MHC-I trafficking
86. A novel human WD protein, h-bTrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif
87. A block to human immunodeficiency virus type 1 assembly in murine cells
88. CD4-independent binding of SIV gp120 to rhesus CCR5
89. CCR5 promoter polymorphism and HW-1 disease progression
90. The transition of HIV-1 gp41 into a six-helix bundle configuration induces membrane fusion
91. Changing virus-host interactions in the course of HIV-1 infection
92. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane rafts
93. Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells
94. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of Gag membrane targeting
95. The origins of HLA-A,B,C polymorphism
96. Mechanism of Nef induced CD4 endocytosis: Nef connects CD4 with the μ chain of adaptor complexes
97. Nef-induced CD4 degradation: A diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of β-COP in endosomes
98. HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes
99. Effects of CCR5 and CD4 cell surface concentrations by macrophage-tropic isolates of human immunodeficiency virus type 1
100. Viral strategies of immune evasion
101. The synaptic SNARE complex is a parallel four-stranded helical bundle
102. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency
103. Equine infection anemia virus utilizes a YXXL motif in the late assembly domain of the Gag p9 protein
104. Identification of an interaction between EIAV Gag p9 protein and cellular AP-2 complex that is critical for virus assembly
105. Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: Comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo
106. A role for carbohydrates in immune evation in AIDS
107. Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4
108. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
109. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral nef protein
110. Proline-rich (PxxP) motifs in HW-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef + viruses but not for down-regulation of CD4
111. Resistance to HIV-1 infection of Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene
112. Gag
113. Downmodulation of MHC-I in a CD4+ T cell line, CEM-E5 after HIV-1 infection
114. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: Replication is restricted at a postentry level
115. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway
116. Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes
117. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein
118. CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages
119. Coiled coils in both intracellular and viral membrane fusion
120. Interleukin 10 increases CCR5 expression and HIV infection in human monocytes
121. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution
122. CD4-dependent, antibody-sensitive interactions between HIV-1 and its coreceptor CCR-5
123. PACS-1 defines a novel gene family of cytosolic sorting proteins required for trans-Golgi network localization
124. Atomic structure of the ectodomain from HIV-1 gp41
125. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
126. The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure
127. Peptides corresponding to a predictive a-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection
128. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
129. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens
130. Identification of the receptor component of the Iκ-Bα-ubiquitin ligase
131. Mechanisms of viral interference with MHC class I antigen processing and presentation
132. CXCR4 is expressed by primary macrophages and supports CCRS-independent infection by dual-tropic but not T-tropic isolates of HIV-1
133. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids